TrialAnnals of oncology : official journal of the European Society for Medical Oncology2012

A randomized trial of a single-dose rasburicase versus five-daily doses in patients at risk for tumor lysis syndrome.

S Vadhan-Raj et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.